SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-018606
Filing Date
2020-01-29
Accepted
2020-01-29 17:26:02
Documents
1
Group Members
F2 BBG LLCF2 BIOSCIENCE II 2017 LTD.F2 CAPITAL I 2017 LTD.F2 CAPITAL I 2019, LLCF2 MG LTD.F2-TPO INVESTMENTS, LLCGLOBEWAYS HOLDINGS II LTD.GLOBEWAYS HOLDINGS LTD.MORANA JOVAN-EMBIRICOS

Document Format Files

Seq Description Document Type Size
1 SC 13G d135690dsc13g.htm SC 13G 197251
  Complete submission text file 0001193125-20-018606.txt   199075
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Subject) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90936 | Film No.: 20559162
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SINGER, MCKEON INC. 8 W 38TH ST STE 1001 NEW YORK NY 10018
Business Address PO BOX 3175 ROAD TOWN TORTOLA D8 VG1110 212-490-0060
F2 Capital I 2015 Ltd (Filed by) CIK: 0001767391 (see all company filings)

IRS No.: 831251751 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G